PresentationGood morning, everyone. Thanks for joining the BofA Healthcare Conferences. My name is Chi Fong, I have [ Dina Ramadane ] with me today, we are both from the U.S. Bio-pharmaceutical Health Care Team here, Bank of America. I cover Roivant, she covers Immunovant. We are glad to be co-hosting CEO of Roivant, Matthew Gline today. Thanks for joining us, Matt.Chi Meng FongBofA Securities, Research Division Okay. Great. Maybe start with some high-level questions, if we may, before we dive into some of ...